{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:54Z","timestamp":1789520694196,"version":"build-2803163510"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Retinal ganglion cell (RGC) death caused by acute ocular hypertension is an important characteristic of acute glaucoma. Receptor-interacting protein kinase 3 (RIPK3) that mediates necroptosis is a potential therapeutic target for RGC death. However, the current understanding of the targeting agents and mechanisms of RIPK3 in the treatment of glaucoma remains limited. Notably, artificial intelligence (AI) technologies have significantly advanced drug discovery. This study aimed to discover RIPK3 inhibitor with AI assistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      An acute ocular hypertension model was used to simulate pathological ocular hypertension\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      . We employed a series of AI methods, including large language and graph neural network models, to identify the target compounds of RIPK3. Subsequently, these target candidates were validated using molecular simulations (molecular docking, absorption, distribution, metabolism, excretion, and toxicity [ADMET] prediction, and molecular dynamics simulations) and biological experiments (Western blotting and fluorescence staining)\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>AI-driven drug screening techniques have the potential to greatly accelerate drug development. A compound called HG9-91-01, identified using AI methods, exerted neuroprotective effects in acute glaucoma. Our research indicates that all five candidates recommended by AI were able to protect the morphological integrity of RGC cells when exposed to hypoxia and glucose deficiency, and HG9-91-01\u00a0showed a higher cell survival rate compared to the other candidates. Furthermore, HG9-91-01 was found to protect the retinal structure and reduce the loss of retinal layers in an acute glaucoma model. It was also observed that the neuroprotective effects of HG9-91-01 were highly correlated with the inhibition of PANoptosis (apoptosis, pyroptosis, and necroptosis). Finally, we found that HG9-91-01 can regulate key proteins related to PANoptosis, indicating that this compound exerts neuroprotective effects in the retina by inhibiting the expression of proteins related to apoptosis, pyroptosis, and necroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>AI\u2010enabled drug discovery revealed that HG9-91-01 could serve as a potential treatment for acute glaucoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003387","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T01:00:11Z","timestamp":1735088411000},"page":"172-184","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model"],"prefix":"10.1097","volume":"138","author":[{"given":"Xing","family":"Tu","sequence":"first","affiliation":[{"name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong 510530, China"},{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"},{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong 510623, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Zou","sequence":"additional","affiliation":[{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"},{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong 510623, China"},{"name":"Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Zeng","sequence":"additional","affiliation":[{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"},{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong 510623, China"},{"name":"Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchao","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Big Data and Biomedical AI, College of Future Technology, Peking University, Beijing 100871, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxu","family":"Gao","sequence":"additional","affiliation":[{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"},{"name":"Institute for Artificial Intelligence in Medicine and Faculty of Medicine, Macau University of Science and Technology, Macao Special Administrative Region 999078, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong 510530, China"},{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong 510623, China"},{"name":"Institute for Artificial Intelligence in Medicine and Faculty of Medicine, Macau University of Science and Technology, Macao Special Administrative Region 999078, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"R1-20250120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R2-20250120","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R3-20250120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"Kang","year":"2021","journal-title":"Med Clin North Am"},{"key":"R4-20250120","doi-asserted-by":"crossref","first-page":"100897","DOI":"10.1016\/j.preteyeres.2020.100897","article-title":"Normal and glaucomatous outflow regulation","volume":"82","author":"Acott","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R5-20250120","doi-asserted-by":"crossref","first-page":"C174","DOI":"10.12968\/hmed.2019.80.12.C174","article-title":"Acute angle closure glaucoma","volume":"80","author":"Flores-S\u00e1nchez","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"R6-20250120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R7-20250120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41419-022-04911-9","article-title":"Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury","volume":"13","author":"Qin","year":"2022","journal-title":"Cell Death Dis"},{"key":"R8-20250120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R9-20250120","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020274","article-title":"Chemical insights into topical agents in intraocular pressure management: from glaucoma etiopathology to therapeutic approaches","volume":"16","author":"Patton","year":"2024","journal-title":"Pharmaceutics"},{"key":"R10-20250120","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"key":"R11-20250120","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"Jama"},{"key":"R12-20250120","doi-asserted-by":"crossref","first-page":"729249","DOI":"10.3389\/fphar.2021.729249","article-title":"Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies","volume":"12","author":"Sharif","year":"2021","journal-title":"Front Pharmacol"},{"key":"R13-20250120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"R14-20250120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/17460441.2015.1000857","article-title":"Discovery of novel inhibitors for the treatment of glaucoma","volume":"10","author":"Cholkar","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"R15-20250120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12974-022-02626-4","article-title":"GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1\/RIP3\/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma","volume":"19","author":"Liu","year":"2022","journal-title":"J Neuroinflammation"},{"key":"R16-20250120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ceo.13336","article-title":"Neuroprotection in glaucoma: recent advances and clinical translation","volume":"47","author":"Guymer","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"R17-20250120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2015.01.001","article-title":"RIPK1 and RIPK3: critical regulators of inflammation and cell death","volume":"25","author":"Newton","year":"2015","journal-title":"Trends Cell Biol"},{"key":"R18-20250120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2022.05.006","article-title":"Necroptosis in heart disease: Molecular mechanisms and therapeutic implications","volume":"169","author":"Guo","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"R19-20250120","doi-asserted-by":"crossref","first-page":"16054","DOI":"10.1038\/cddiscovery.2016.54","article-title":"Retinal pigment epithelial cell necroptosis in response to sodium iodate","volume":"2","author":"Hanus","year":"2016","journal-title":"Cell Death Discov"},{"key":"R20-20250120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/cdd.2013.109","article-title":"Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration","volume":"21","author":"Murakami","year":"2014","journal-title":"Cell Death Differ"},{"key":"R21-20250120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/abbs\/gmx088","article-title":"Mixed lineage kinase domain-like protein induces RGC-5 necroptosis following elevated hydrostatic pressure","volume":"49","author":"Liao","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R22-20250120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/abbs\/gmw130","article-title":"The effects and regulatory mechanism of RIP3 on RGC-5 necroptosis following elevated hydrostatic pressure","volume":"49","author":"Shang","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R23-20250120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12868-015-0187-x","article-title":"Receptor interacting protein 3-induced RGC-5 cell necroptosis following oxygen glucose deprivation","volume":"16","author":"Ding","year":"2015","journal-title":"BMC Neurosci"},{"key":"R24-20250120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02713683.2016.1227449","article-title":"Ischemia Reperfusion Injury Triggers TNF\u03b1 Induced-Necroptosis in Rat Retina","volume":"42","author":"Kim","year":"2017","journal-title":"Curr Eye Res"},{"key":"R25-20250120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2202-14-16","article-title":"Differential neuronal expression of receptor interacting protein 3 in rat retina: involvement in ischemic stress response","volume":"14","author":"Huang","year":"2013","journal-title":"BMC Neurosci"},{"key":"R26-20250120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41419-023-05660-z","article-title":"RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy","volume":"14","author":"Huang","year":"2023","journal-title":"Cell Death Dis"},{"key":"R27-20250120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.64.14.42","article-title":"GSK840\u00a0Alleviates Retinal Neuronal Injury by Inhibiting RIPK3\/MLKL-Mediated RGC Necroptosis After Ischemia\/Reperfusion","volume":"64","author":"Feng","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-20250120","doi-asserted-by":"crossref","first-page":"1166120","DOI":"10.3389\/fpubh.2023.1166120","article-title":"ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health","volume":"11","author":"De Angelis","year":"2023","journal-title":"Front Public Health"},{"key":"R30-20250120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s42254-023-00581-4","article-title":"Science in the age of large language models","volume":"5","author":"Birhane","year":"2023","journal-title":"Nat Rev Phys"},{"key":"R31-20250120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-023-06792-0","article-title":"Autonomous chemical research with large language models","volume":"624","author":"Boiko","year":"2023","journal-title":"Nature"},{"key":"R32-20250120","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/bib\/bbaa044","article-title":"Identifying drug-target interactions based on graph convolutional network and deep neural network","volume":"22","author":"Zhao","year":"2021","journal-title":"Brief Bioinform"},{"key":"R33-20250120","doi-asserted-by":"crossref","first-page":"107136","DOI":"10.1016\/j.compbiomed.2023.107136","article-title":"A survey of drug-target interaction and affinity prediction methods via graph neural networks","volume":"163","author":"Zhang","year":"2023","journal-title":"Comput Biol Med"},{"key":"R34-20250120","doi-asserted-by":"crossref","first-page":"114798","DOI":"10.1016\/j.bcp.2021.114798","article-title":"Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application","volume":"194","author":"Ren","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R35-20250120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.04.009","article-title":"Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia\u2013reperfusion-induced retinal damage","volume":"123","author":"Dvoriantchikova","year":"2014","journal-title":"Exp Eye Rese"},{"key":"R36-20250120","first-page":"18","article-title":"Intravitreal injection of PACAP attenuates acute ocular hypertension-induced retinal injury via anti-apoptosis and anti-inflammation in mice","volume":"63","author":"Lu","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20250120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41419-022-04633-y","article-title":"Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R38-20250120","doi-asserted-by":"crossref","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","article-title":"Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL","volume":"288","author":"Kaiser","year":"2013","journal-title":"J Biol Chem"},{"key":"R39-20250120","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1038\/cddis.2014.241","article-title":"The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"R40-20250120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/ml4000063","article-title":"Discovery of dabrafenib: a selective inhibitor of raf kinases with antitumor activity against b-raf-driven tumors","volume":"4","author":"Rheault","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"R41-20250120","first-page":"1","article-title":"HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis","volume":"50","author":"Park","year":"2018","journal-title":"Exp Mol Med"},{"key":"R42-20250120","doi-asserted-by":"crossref","first-page":"109262","DOI":"10.1016\/j.intimp.2022.109262","article-title":"RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation","volume":"112","author":"Xu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R43-20250120","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","article-title":"GraphDTA: predicting drug-target binding affinity with graph neural networks","volume":"37","author":"Nguyen","year":"2021","journal-title":"Bioinformatics"},{"key":"R44-20250120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1039\/D1SC05180F","article-title":"MGraphDTA: deep multiscale graph neural network for explainable drug-target binding affinity prediction","volume":"13","author":"Yang","year":"2022","journal-title":"Chem Sci"},{"key":"R45-20250120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12864-022-08648-9","article-title":"Sequence-based drug-target affinity prediction using weighted graph neural networks","volume":"23","author":"Jiang","year":"2022","journal-title":"BMC Genomics"},{"key":"R46-20250120","article-title":"Pharmaceutical therapies for necroptosis in myocardial ischemia-reperfusion injury","volume":"10","author":"Zhang","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"R47-20250120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-immunol-112019-072301","article-title":"The antisocial network: cross talk between cell death programs in host defense","volume":"39","author":"Snyder","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"R48-20250120","doi-asserted-by":"crossref","DOI":"10.1089\/dna.2023.0106","article-title":"LncRNA Gm44206 promotes microglial pyroptosis through NLRP3\/Caspase-1\/GSDMD axis and aggravate cerebral ischemia-reperfusion injury","author":"Yang","year":"2023","journal-title":"DNA and Cell Biology"},{"key":"R49-20250120","doi-asserted-by":"crossref","first-page":"e12828","DOI":"10.1111\/jpi.12828","article-title":"Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model","volume":"73","author":"Ye","year":"2022","journal-title":"J Pineal Res"},{"key":"R50-20250120","first-page":"357","article-title":"PANoptosis-like cell death in ischemia\/reperfusion injury of retinal neurons","volume":"18","author":"Yan","year":"2023","journal-title":"Neural Regen Res"},{"key":"R51-20250120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R52-20250120","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.redox.2023.102713","article-title":"Translocator protein 18\u00a0kDa regulates retinal neuron apoptosis and pyroptosis in glaucoma","volume":"63","author":"Zeng","year":"2023","journal-title":"Redox Biol"},{"key":"R53-20250120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41418-019-0351-4","article-title":"LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia\/reperfusion injury","volume":"27","author":"Wan","year":"2020","journal-title":"Cell death and differentiation"},{"key":"R54-20250120","doi-asserted-by":"crossref","first-page":"911430","DOI":"10.3389\/fnins.2022.911430","article-title":"Necroptosis and neuroinflammation in retinal degeneration","volume":"16","author":"Tao","year":"2022","journal-title":"Front Neurosci"},{"key":"R55-20250120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"R56-20250120","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3390\/ijms24032985","article-title":"Erythropoietin in glaucoma: from mechanism to therapy","volume":"24","author":"Lai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R57-20250120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of neuroprotection in glaucoma","volume":"34","author":"He","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"key":"R58-20250120","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1002\/mef2.15","article-title":"Evaluation of neuroprotective agents acting via the BDNF\u2013TrkB pathway using AI-enabled predictions of ligand\u2013receptor interactions","volume":"1","author":"Zhu","year":"2022","journal-title":"MedComm\u2013Future Med"},{"key":"R59-20250120","doi-asserted-by":"crossref","first-page":"101193","DOI":"10.1016\/j.mam.2023.101193","article-title":"Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering","volume":"92","author":"Tribble","year":"2023","journal-title":"Mol Aspects Med"},{"key":"R60-20250120","first-page":"170","article-title":"Glaucoma in adults-diagnosis, management, and prediagnosis to end-stage, categorizing glaucoma\u2019s stages: a review","volume":"16","author":"Joshi","year":"2022","journal-title":"J Curr Glaucoma Pract"},{"key":"R61-20250120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41433-020-01215-0","article-title":"Aqueous humour outflow imaging: seeing is believing","volume":"35","author":"Lee","year":"2021","journal-title":"Eye (Lond)"},{"key":"R62-20250120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/ICU.0b013e32834ff23e","article-title":"Current understanding of conventional outflow dysfunction in glaucoma","volume":"23","author":"Stamer","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"R63-20250120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the collaborative initial glaucoma treatment study the impact of treatment and other baseline factors","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"R64-20250120","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ophtha.2009.05.026","article-title":"Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients","volume":"116","author":"Okeke","year":"2009","journal-title":"Ophthalmology"},{"key":"R65-20250120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ceo.14052","article-title":"The changing glaucoma treatment paradigm","volume":"50","author":"Kerr","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"R66-20250120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cells8121486","article-title":"Molecular insights into the mechanism of necroptosis: the necrosome as a potential therapeutic target","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"R67-20250120","doi-asserted-by":"crossref","first-page":"917155","DOI":"10.3389\/fimmu.2022.917155","article-title":"Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"R68-20250120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mco2.108","article-title":"The role of necroptosis in disease and treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm (2020)"},{"key":"R69-20250120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41419-019-2094-z","article-title":"Current translational potential and underlying molecular mechanisms of necroptosis","volume":"10","author":"Moln\u00e1r","year":"2019","journal-title":"Cell Death Dis"},{"key":"R70-20250120","first-page":"771","article-title":"RIP1\/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)","volume":"44","author":"Liu","year":"2019","journal-title":"Int J Mol Med"},{"key":"R71-20250120","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/cdd.2014.76","article-title":"RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis","volume":"21","author":"Orozco","year":"2014","journal-title":"Cell Death Differ"},{"key":"R72-20250120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","article-title":"MK2 phosphorylates RIPK1 to prevent TNF-induced cell death","volume":"66","author":"Jaco","year":"2017","journal-title":"Mol Cell"},{"key":"R73-20250120","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1111\/febs.13034","article-title":"RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis","volume":"281","author":"Kearney","year":"2014","journal-title":"Febs J"},{"key":"R74-20250120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cdd.2017.141","article-title":"Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation","volume":"25","author":"Huang","year":"2018","journal-title":"Cell Death Differ"},{"key":"R75-20250120","doi-asserted-by":"crossref","first-page":"107922","DOI":"10.1016\/j.exer.2020.107922","article-title":"Involvement of regulated necrosis in blinding diseases: Focus on necroptosis and ferroptosis","volume":"191","author":"Peng","year":"2020","journal-title":"Exp Eye Res"},{"key":"R76-20250120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arr.2015.09.002","article-title":"RPE necroptosis in response to oxidative stress and in AMD","volume":"24","author":"Hanus","year":"2015","journal-title":"Ageing Res Rev"},{"key":"R77-20250120","doi-asserted-by":"crossref","first-page":"e2023290118","DOI":"10.1073\/pnas.2023290118","article-title":"A specific RIP3(+) subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism","volume":"118","author":"He","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R78-20250120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joa.13185","article-title":"RSK3\u00a0mediates necroptosis by regulating phosphorylation of RIP3 in rat retinal ganglion cells","volume":"237","author":"Wang","year":"2020","journal-title":"J Anat"},{"key":"R79-20250120","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"R80-20250120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.immuni.2020.07.004","article-title":"Flexible usage and interconnectivity of diverse cell death pathways protect against intracellular infection","volume":"53","author":"Doerflinger","year":"2020","journal-title":"Immunity"},{"key":"R81-20250120","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","article-title":"FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells","volume":"52","author":"Schwarzer","year":"2020","journal-title":"Immunity"},{"key":"R82-20250120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cdd.2014.216","article-title":"Old, new and emerging functions of caspases","volume":"22","author":"Shalini","year":"2015","journal-title":"Cell Death Differ"},{"key":"R83-20250120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","article-title":"Cleavage of RIPK1 by caspase-8\u00a0is crucial for limiting apoptosis and necroptosis","volume":"574","author":"Newton","year":"2019","journal-title":"Nature"},{"key":"R84-20250120","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.cellsig.2007.05.016","article-title":"Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain","volume":"19","author":"Feng","year":"2007","journal-title":"Cell Signal"},{"key":"R85-20250120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","article-title":"Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis","volume":"471","author":"Oberst","year":"2011","journal-title":"Nature"},{"key":"R86-20250120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","article-title":"RIP3\u00a0mediates the embryonic lethality of caspase-8-deficient mice","volume":"471","author":"Kaiser","year":"2011","journal-title":"Nature"},{"key":"R87-20250120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R88-20250120","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.cell.2023.05.027","article-title":"Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine","volume":"186","author":"He","year":"2023","journal-title":"Cell"},{"key":"R89-20250120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"R90-20250120","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/s41467-019-09753-2","article-title":"Caspase-1 initiates apoptosis in the absence of gasdermin D","volume":"10","author":"Tsuchiya","year":"2019","journal-title":"Nat Commun"},{"key":"R91-20250120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"R92-20250120","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2147\/JIR.S403819","article-title":"PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis","volume":"16","author":"Shi","year":"2023","journal-title":"J Inflamm Res"},{"key":"R93-20250120","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/cells11091495","article-title":"It\u2019s all in the PAN: crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by PANoptosis underlying the totality of cell death-associated biological effects","volume":"11","author":"Gullett","year":"2022","journal-title":"Cells"},{"key":"R94-20250120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12974-021-02366-x","article-title":"Interplay between M\u00fcller cells and microglia aggravates retinal inflammatory response in experimental glaucoma","volume":"18","author":"Hu","year":"2021","journal-title":"J Neuroinflammation"},{"key":"R95-20250120","doi-asserted-by":"crossref","first-page":"100976","DOI":"10.1016\/j.preteyeres.2021.100976","article-title":"Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic","volume":"86","author":"Cordeiro","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R96-20250120","doi-asserted-by":"crossref","first-page":"109109","DOI":"10.1016\/j.exer.2022.109109","article-title":"Interleukin-35\u00a0suppresses pyroptosis and protects against neuronal death in retinal ischaemia\/reperfusion injury","volume":"220","author":"Lin","year":"2022","journal-title":"Exp Eye Res"},{"key":"R97-20250120","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190930","article-title":"Neuronal Epac1\u00a0mediates retinal neurodegeneration in mouse models of ocular hypertension","volume":"217","author":"Liu","year":"2020","journal-title":"J Exp Med"},{"key":"R98-20250120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: Resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"R99-20250120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"R100-20250120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt1273","article-title":"Structure-based maximal affinity model predicts small-molecule druggability","volume":"25","author":"Cheng","year":"2007","journal-title":"Nature Biotechnology"},{"key":"R101-20250120","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","article-title":"Deep learning in drug discovery: an integrative review and future challenges","volume":"56","author":"Askr","year":"2023","journal-title":"Artif Intell Rev"},{"key":"R102-20250120","doi-asserted-by":"crossref","first-page":"25218","DOI":"10.1039\/D3RA03796G","article-title":"iEdgeDTA: integrated edge information and 1D graph convolutional neural networks for binding affinity prediction","volume":"13","author":"Suviriyapaisal","year":"2023","journal-title":"RSC Advances"},{"key":"R103-20250120","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acs.jcim.2c00327","article-title":"ACGCN: graph convolutional networks for activity cliff prediction between matched molecular pairs","volume":"62","author":"Park","year":"2022","journal-title":"J Chem Inf Model"},{"key":"R104-20250120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s42256-022-00501-8","article-title":"An adaptive graph learning method for automated molecular interactions and properties predictions","volume":"4","author":"Li","year":"2022","journal-title":"Nat Mach Intel"},{"key":"R105-20250120","doi-asserted-by":"crossref","first-page":"18209","DOI":"10.1021\/acs.jmedchem.1c01830","article-title":"InteractionGraphNet: a novel and efficient deep graph representation learning framework for accurate protein\u2013ligand interaction predictions","volume":"64","author":"Jiang","year":"2021","journal-title":"J Med Chem"},{"key":"R106-20250120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aiopen.2021.01.001","article-title":"Graph neural networks: A review of methods and applications","volume":"1","author":"Zhou","year":"2020","journal-title":"AI Open"},{"key":"R107-20250120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neunet.2020.06.006","article-title":"A gentle introduction to deep learning for graphs","volume":"129","author":"Bacciu","year":"2020","journal-title":"Neural Networks"},{"key":"R108-20250120","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/acs.jcim.2c00127","article-title":"Predicting protein-ligand docking structure with graph neural network","volume":"62","author":"Jiang","year":"2022","journal-title":"J Chem Inf Model"},{"key":"R109-20250120","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1038\/s41467-021-27032-x","article-title":"Human RIPK3\u00a0maintains MLKL in an inactive conformation prior to cell death by necroptosis","volume":"12","author":"Meng","year":"2021","journal-title":"Nat Commun"},{"key":"R110-20250120","doi-asserted-by":"crossref","first-page":"103159","DOI":"10.1016\/j.jbi.2019.103159","article-title":"A comprehensive review of feature based methods for drug target interaction prediction","volume":"93","author":"Sachdev","year":"2019","journal-title":"J Biomed Inform"},{"key":"R111-20250120","doi-asserted-by":"crossref","first-page":"680117","DOI":"10.3389\/fgene.2021.680117","article-title":"Application of Machine Learning for Drug-Target Interaction Prediction","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"R112-20250120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief Bioinform"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:33Z","timestamp":1786041633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003387","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}